Genetics of prostate cancer.

Prostate cancer is the most frequently diagnosed visceral cancer of men, responsible for approximately 40,000 deaths in adult males per year. To identify the genetic causes of prostate cancer, we performed a whole genome scan of affected sib pairs, using DNA markers spaced evenly across the human genome. We demonstrated that regions on chromosomes 1, 4, 5, 7, 8, 11, 16 and 19 might harbor genes that predispose individuals to prostate cancer and may affect tumor growth rate and tumor aggressiveness. Here we present DNA sequence analysis of KIAA 0872 and 17-beta hydroxysteroid dehydrogenase that are located on chromosome 16 within the mapped region, and we demonstrate that neither of these genes carries mutations in the protein coding region or their splice junction sites. These results suggest that these genes are less likely to be associated with the cause of familial prostate cancer.

[1]  R. Dahiya,et al.  Deletion of chromosome 11p15, p12, q22, q23‐24 loci in human prostate cancer , 1997, International journal of cancer.

[2]  E. Goode,et al.  A genomic scan of families with prostate cancer identifies multiple regions of interest. , 2000, American journal of human genetics.

[3]  K. Cooney,et al.  Distinct regions of allelic loss on 13q in prostate cancer. , 1996, Cancer research.

[4]  T. Mashimo,et al.  Human chromosome 16 suppresses metastasis but not tumorigenesis in rat prostatic tumor cells. , 1998, Cancer research.

[5]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[6]  J. Simard,et al.  The human type II 17 beta-hydroxysteroid dehydrogenase gene encodes two alternatively spliced mRNA species. , 1995, DNA and cell biology.

[7]  M. Poutanen,et al.  Loss of heterozygosity at 16q24.1-q24.2 is significantly associated with metastatic and aggressive behavior of prostate cancer. , 1997, Cancer research.

[8]  F. Bosman,et al.  Loss of heterozygosity of chromosome 8 microsatellite loci implicates a candidate tumor suppressor gene between the loci D8S87 and D8S133 in human prostate cancer. , 1994, Cancer research.

[9]  J. Weissenbach,et al.  Loss of the chromosomal region 10q23-25 in prostate cancer. , 1995, Cancer research.

[10]  D. Bostwick,et al.  Frequent loss of heterozygosity at 7q31.1 in primary prostate cancer is associated with tumor aggressiveness and progression. , 1995, Cancer research.

[11]  S. Odelberg,et al.  Loss of Chromosome 17 loci in prostate cancer detected by polymerase chain reaction quantitation of allelic markers , 1995, Genes, chromosomes & cancer.

[12]  T. Glover,et al.  Distinct areas of allelic loss on chromosomal regions 10p and 10q in human prostate cancer. , 1996, Cancer research.

[13]  T. Rebbeck,et al.  Association of HPC2/ELAC2 genotypes and prostate cancer. , 2000, American journal of human genetics.

[14]  M. Emi,et al.  Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers , 1996, Genes, chromosomes & cancer.

[15]  J. Witte,et al.  A genome screen of multiplex sibships with prostate cancer. , 2000, American journal of human genetics.

[16]  Siavash Ghaffari,et al.  A candidate prostate cancer susceptibility gene at chromosome 17p , 2001, Nature Genetics.

[17]  D V Conti,et al.  Genomewide scan for prostate cancer-aggressiveness loci. , 2000, American journal of human genetics.

[18]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[19]  J. Witte,et al.  Replication linkage study for prostate cancer susceptibility genes , 2000, The Prostate.

[20]  Meikle Aw,et al.  Epidemiology of prostate cancer. , 1990, The Urologic clinics of North America.

[21]  D. Gerhard,et al.  Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls. , 2001, Cancer research.

[22]  K. Pienta,et al.  Epidemiology of prostate cancer: molecular and environmental clues. , 1996, Urology.

[23]  W. Catalona,et al.  Contemporary results of anatomic radical prostatectomy , 1999, CA: a cancer journal for clinicians.

[24]  D. Grignon,et al.  Loss of heterozygosity of the BRCA1 and other loci on chromosome 17q in human prostate cancer. , 1995, Cancer research.

[25]  K. Klinger,et al.  Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 , 2002, Nature Genetics.

[26]  S. Marcella,et al.  Ethnic and racial differences in prostate cancer incidence and mortality. , 2000, Ethnicity & disease.

[27]  W. Sakr,et al.  Loss of the 17p chromosomal region in a metastatic carcinoma of the prostate. , 1992, The Journal of urology.

[28]  J. Krieger,et al.  Short tandem repeat polymorphism linkage to the androgen receptor gene in prostate carcinoma , 2001, Cancer.

[29]  P. Humphrey,et al.  Clinical and pathological features of hereditary prostate cancer. , 1996, The Journal of urology.

[30]  G. Bubley,et al.  Frequent abnormalities of TSG101 transcripts in human prostate cancer , 1997, Oncogene.

[31]  A. Bednarek,et al.  WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer. , 2000, Cancer research.

[32]  T. Beaty,et al.  Mendelian inheritance of familial prostate cancer. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[34]  M. Ittmann.  Loss of heterozygosity on chromosomes 10 and 17 in clinically localized prostate carcinoma , 1996, The Prostate.

[35]  M. Poutanen,et al.  Human 17β-Hydroxysteroid Dehydrogenase Type 2 Messenger Ribonucleic Acid Expression and Localization in Term Placenta and in Endometrium during the Menstrual Cycle1 , 1998 .

[36]  D J Schaid,et al.  Evidence for a prostate cancer-susceptibility locus on chromosome 20. , 2000, American journal of human genetics.

[37]  N. Risch,et al.  The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[38]  J. Witte,et al.  Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. , 2000, Cancer research.

[39]  F. Collins,et al.  Evidence for a prostate cancer susceptibility locus on the X chromosome. , 1998, Nature Genetics.